Enanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus (RSV) Business Wire
Rivera-Mariani extends respiratory virus forecasting in Puerto Rico Lynn University
Maternal Respiratory Syncytial Virus Vaccination Reduces Infant Hospitalization in Early Findings Physician's Weekly
What Is RSV? Recognise Respiratory Viruses to Watch Out For SBS Australia
Maternal RSV vaccine shows 68% protection against infant RSV hospitalization News-Medical
Vaccines for Adults | RSV Centers for Disease Control and Prevention | CDC (.gov)
Respiratory syncytial virus (RSV) Infant Monoclonal Antibody Administration Extension KDHE (.gov)
Can RSV Cause a Rash? Verywell Health
Respiratory syncytial virus (RSV) in adults: risk and vaccination Hospital Clínic Barcelona
Maternal RSV Vaccination Cut Infant Hospitalization Risk by 80% respiratory-therapy.com
Getting the RSV vaccine during pregnancy is a game-changer for infant hospitalizations CIDRAP
In vitro liquid-liquid phase separation induced by respiratory syncytial virus proteins and RNA Science | AAAS
Interactions of SARS-CoV-2, influenza and respiratory syncytial virus influence epidemic timing and risk Nature
Respiratory virus vaccines: Clinical guidance and resources American Academy of Family Physicians | AAFP
Respiratory Illnesses Data Channel Centers for Disease Control and Prevention | CDC (.gov)
The soluble G protein of respiratory syncytial virus promotes viral dissemination via TLR2-mediated NLRP3 priming and pyroptosis Nature
RSV symptoms in older adults often linger, studies show CIDRAP
β2-adrenergic signaling controls neonatal respiratory syncytial virus infection by promoting viral clearance and airway protection Nature
Correlates of risk of respiratory syncytial virus disease: a prospective cohort study Nature
Mathematical analysis of a stochastic delay model for respiratory syncytial virus dynamics Nature
Real-time prediction of influenza and respiratory syncytial virus epidemics in primary care using the Gompertz model Nature
Catching our breath: development of interventions and therapies for respiratory syncytial virus ASM Journals
Current and Emerging Strategies for the Prevention of Respiratory Syncytial Virus (RSV) Infections: A Comprehensive Review of Vaccines and Antibody Therapies Cureus
Short-term environmental changes and respiratory syncytial virus infection in Chile Nature
Whole-genome nanopore sequencing and automatic downstream analysis of respiratory syncytial virus using RSVTyper Nature
Respiratory Syncytial Virus (RSV): A Comprehensive Overview From Basic Biology to Clinical Prevention and Control Wiley Online Library
Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75–79 years in England: a multicentre, test-negative, case–control study The Lancet
RSV Admission May Raise Risk for Cardiorespiratory Events Medscape
Nirsevimab may help prevent severe respiratory illnesses beyond RSV in infants, young kids CIDRAP
Respiratory syncytial virus (RSV) resources American Medical Association
Hospitalisation and healthcare burden of respiratory syncytial virus in adults over 50 years in France medRxiv
The path to equitable respiratory syncytial virus prevention for infants: challenges and opportunities for global implementation The Lancet
Severe Respiratory Syncytial Virus Bronchiolitis Complicated by Bilateral Massive Pleural Effusions in a Previously Healthy Infant: A Case Report Cureus
RSV facts you need to know: What to expect during its winter peak UT Physicians
RSV vaccine protects older adults, and drug protects babies, but less so over time, studies suggest CIDRAP
Studies: RSV prevention strategies—especially nirsevimab—may cut infant hospitalizations CIDRAP
Universal nirsevimab slashes RSV infant hospitalizations, study suggests CIDRAP
A living systematic review and meta analysis on the efficacy and safety of respiratory syncytial virus vaccines European Centre for Disease Prevention and Control (ECDC)
RSV Is Still Surging in These 9 States, Hitting Kids Under 4 the Hardest. When Will the Season End? TODAY.com
Respiratory Virus Hospitalization Surveillance Network (RESP-NET) Centers for Disease Control and Prevention | CDC (.gov)